Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036)

Clinical trial NCT04633226 · COMPLETED

Trial details

NCT number: NCT04633226
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2021-02-10
Primary completion: 2022-11-04
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.